Your weekly roundup of the latest news from Drug Topics®.
The bill allows state attorneys general and the Federal Trade Commission the ability to initiate legal action against certain PBM business practices.
While antibiotic dosing was correct, therapy duration was frequently inappropriate.
Medication decision support tools focused on individual patients can help pharmacists effectively analyze risk of unintended harm, identify and assess potential interventions, and facilitate longitudinal care.
Study investigators hope these results are reassuring.
Current data about naloxone use in pediatric populations is extrapolated from adult studies.